 Kamada Ltd. NASDAQ TASE: KMDA, a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2019, prior to the open of the U.S. financial markets on Wednesday, February 12, 2020. Kamada management will host an investment community conference call on Wednesday, February 12, at 8:30am Eastern Time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 877-407-0792 from within the U.S., 1809 406 247 from Israel, or 201-689-8263 International and entering the conference identification number: 13698675. 